Cargando…

An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria

Enteric hyperoxaluria (EH) is a metabolic disease caused by excessive absorption of dietary oxalate leading to the formation of chronic kidney stones and kidney failure. There are no approved pharmaceutical treatments for EH. SYNB8802 is an engineered bacterial therapeutic designed to consume oxalat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lubkowicz, David, Horvath, Nicholas G, James, Michael J, Cantarella, Pasquale, Renaud, Lauren, Bergeron, Christopher G, Shmueli, Ron B, Anderson, Cami, Gao, Jian‐Rong, Kurtz, Caroline B, Perreault, Mylene, Charbonneau, Mark R, Isabella, Vincent M, Hava, David L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899768/ https://www.ncbi.nlm.nih.gov/pubmed/35253995 http://dx.doi.org/10.15252/msb.202110539

Ejemplares similares

In vivo oxalate degradation by liposome encapsulated oxalate oxidase in rat model of hyperoxaluria
por: Dahiya, Tulika, et al.
Publicado: (2013)

Dominant negative mutation in oxalate transporter SLC26A6 associated with enteric hyperoxaluria and nephrolithiasis
por: Cornière, Nicolas, et al.
Publicado: (2022)

Enteric hyperoxaluria in chronic pancreatitis
por: Demoulin, Nathalie, et al.
Publicado: (2017)

Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) Registry
por: Metry, Elisabeth L., et al.
Publicado: (2021)

Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort
por: Shah, Ronak Jagdeep, et al.
Publicado: (2020)

Plasma oxalate and glycolate concentrations in dialysis patients with and without primary hyperoxaluria type 1
por: Metry, Elisabeth L, et al.
Publicado: (2023)

A Successful Approach to Kidney Transplantation in Patients With Enteric (Secondary) Hyperoxaluria
por: Roodnat, Joke I., et al.
Publicado: (2017)

Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria
por: Lai, Chengjung, et al.
Publicado: (2018)

Hydroxycitric Acid Tripotassium Inhibits Calcium Oxalate Crystal Formation in the Drosophila Melanogaster Model of Hyperoxaluria
por: Han, Shanfu, et al.
Publicado: (2019)

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria
por: Wang, Xiangling, et al.
Publicado: (2020)

Chronic liver disease and hepatic calcium-oxalate deposition in patients with primary hyperoxaluria type I
por: Recker, Pia, et al.
Publicado: (2022)

Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass
por: Agrawal, Varun, et al.
Publicado: (2016)

Pilot study of reloxaliase in patients with severe enteric hyperoxaluria and hyperoxalemia
por: Pfau, Anja, et al.
Publicado: (2021)

Primary hyperoxaluria type 1: urologic and therapeutic management
por: Kohli, Harjivan, et al.
Publicado: (2022)

Transplantation for renal failure secondary to enteric hyperoxaluria: a case report
por: Rifkin, Stephen I
Publicado: (2007)

Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures
por: Suryavanshi, Mangesh V., et al.
Publicado: (2016)

Transcriptional study of hyperoxaluria and calcium oxalate nephrolithiasis in male rats: Inflammatory changes are mainly associated with crystal deposition
por: Joshi, Sunil, et al.
Publicado: (2017)

Kidney Injury Molecule-1 Is Up-Regulated in Renal Epithelial Cells in Response to Oxalate In Vitro and in Renal Tissues in Response to Hyperoxaluria In Vivo
por: Khandrika, Lakshmipathi, et al.
Publicado: (2012)

Autophagy inhibition attenuates hyperoxaluria-induced renal tubular oxidative injury and calcium oxalate crystal depositions in the rat kidney
por: Duan, Xiaolu, et al.
Publicado: (2018)

Primary Hyperoxaluria
por: Harambat, Jérôme, et al.
Publicado: (2011)

Evaluation of a high‐performance liquid chromatography method for urinary oxalate determination and investigation regarding the pediatric reference interval of spot urinary oxalate to creatinine ratio for screening of primary hyperoxaluria
por: Shen, Ying, et al.
Publicado: (2021)

Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies
por: Milliner, Dawn S., et al.
Publicado: (2021)

Cerium oxide-based nanozyme suppresses kidney calcium oxalate crystal depositions via reversing hyperoxaluria-induced oxidative stress damage
por: Deng, Jiwang, et al.
Publicado: (2022)

Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium
por: Metry, Elisabeth L., et al.
Publicado: (2023)

Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1
por: Dutta, Chaitali, et al.
Publicado: (2016)

Retraction: Kidney Injury Molecule-1 Is Up-Regulated in Renal Epithelial Cells in Response to Oxalate In Vitro and in Renal Tissues in Response to Hyperoxaluria In Vivo
Publicado: (2020)

Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster
por: Kalantari, Aida, et al.
Publicado: (2023)

Treatment of primary hyperoxaluria type 1
por: Gupta, Asheeta, et al.
Publicado: (2022)

Frequency and impact of enteric hyperoxaluria in pediatric short bowel syndrome: a retrospective single centre study
por: Schaefer, Jan Thomas, et al.
Publicado: (2023)

Correction to Retraction of: Kidney Injury Molecule-1 Is Up-Regulated in Renal Epithelial Cells in Response to Oxalate In Vitro and in Renal Tissues in Response to Hyperoxaluria In Vivo
Publicado: (2020)

Exosomes from miR-23 Overexpressing Stromal Cells Suppress M1 Macrophage and Inhibit Calcium Oxalate Deposition in Hyperoxaluria Rat Model
por: Yifan, Zhang, et al.
Publicado: (2023)

Primary hyperoxaluria and systemic oxalosis
por: Sriram, K., et al.
Publicado: (2007)

Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion
por: Crivelli, Joseph J., et al.
Publicado: (2020)

ALLN-177, oral enzyme therapy for hyperoxaluria
por: Lingeman, James E., et al.
Publicado: (2019)

Compliance in patients with dietary hyperoxaluria: A cohort study and systematic review
por: Hennessey, Derek B., et al.
Publicado: (2019)

Pancytopenia as a Complication of Primary Hyperoxaluria
por: Khosravi, M., et al.
Publicado: (2019)

The Struggling Odyssey of Infantile Primary Hyperoxaluria
por: Guillaume, Adrien, et al.
Publicado: (2021)

Improving Treatment Options for Primary Hyperoxaluria
por: Hoppe, Bernd, et al.
Publicado: (2022)

Primary hyperoxaluria: a case series
por: Rather, Jawad Iqbal, et al.
Publicado: (2023)

In female rats, ethylene glycol treatment elevates protein expression of hepatic and renal oxalate transporter sat-1 (Slc26a1) without inducing hyperoxaluria
por: Breljak, Davorka, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jekg82kermtg9jjs94gtffo1gb